The Clorox Company (NYSE:CLX) Holdings Lowered by Bard Financial Services Inc.

Bard Financial Services Inc. reduced its holdings in The Clorox Company (NYSE:CLXFree Report) by 77.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,675 shares of the company’s stock after selling 5,675 shares during the period. Bard Financial Services Inc.’s holdings in Clorox were worth $273,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the business. CIBC Private Wealth Group LLC raised its stake in shares of Clorox by 0.5% during the 4th quarter. CIBC Private Wealth Group LLC now owns 13,900 shares of the company’s stock worth $1,982,000 after purchasing an additional 66 shares in the last quarter. Fiduciary Group LLC increased its position in Clorox by 0.4% in the 2nd quarter. Fiduciary Group LLC now owns 19,050 shares of the company’s stock worth $2,600,000 after buying an additional 72 shares during the period. GHP Investment Advisors Inc. increased its position in Clorox by 2.0% in the 2nd quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company’s stock worth $496,000 after buying an additional 72 shares during the period. SPC Financial Inc. increased its position in Clorox by 2.2% in the 2nd quarter. SPC Financial Inc. now owns 3,485 shares of the company’s stock worth $476,000 after buying an additional 75 shares during the period. Finally, Massmutual Trust Co. FSB ADV increased its position in shares of Clorox by 17.2% during the third quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock valued at $83,000 after purchasing an additional 75 shares during the period. 78.53% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have recently issued reports on CLX shares. Citigroup boosted their price objective on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research report on Friday, September 6th. TD Cowen assumed coverage on Clorox in a research note on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 price objective on the stock. Barclays upped their price target on Clorox from $122.00 to $130.00 and gave the company an “underweight” rating in a research note on Monday, August 5th. JPMorgan Chase & Co. dropped their price objective on Clorox from $150.00 to $148.00 and set a “neutral” rating for the company in a report on Friday, August 2nd. Finally, DA Davidson reiterated a “neutral” rating and issued a $153.00 price objective on shares of Clorox in a report on Friday, September 6th. Six equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, Clorox has a consensus rating of “Hold” and a consensus target price of $146.13.

Get Our Latest Report on CLX

Clorox Stock Up 0.1 %

Shares of CLX stock traded up $0.20 on Friday, hitting $161.57. 798,281 shares of the stock were exchanged, compared to its average volume of 1,250,263. The company has a current ratio of 1.03, a quick ratio of 0.63 and a debt-to-equity ratio of 5.04. The firm has a market capitalization of $20.07 billion, a P/E ratio of 83.72, a price-to-earnings-growth ratio of 3.31 and a beta of 0.41. The business has a 50-day moving average of $154.91 and a 200 day moving average of $144.43. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $169.09.

Clorox (NYSE:CLXGet Free Report) last issued its quarterly earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, beating the consensus estimate of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The firm had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.97 billion. Equities analysts anticipate that The Clorox Company will post 6.63 EPS for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a yield of 3.02%. Clorox’s dividend payout ratio (DPR) is presently 252.85%.

Insider Activity

In other news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at $2,229,719.92. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Insiders own 0.51% of the company’s stock.

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.